腹部大動脈ステントグラフト市場：パイプラインレポート（開発段階、セグメント、地域・国、規制経路、主要企業）、2024最新版

腹部大動脈ステントグラフトは、低侵襲手技を用いて大動脈の一部を補強することにより、腹部大動脈瘤の治療に使用されます。

当レポートでは、腹部大動脈ステントグラフト市場について調査し、製品概要と開発中のパイプライン製品動向、様々な開発段階にある製品の比較分析や進行中の臨床試験に関する情報、参入企業の最近の動向などを提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 腹部大動脈ステントグラフト - 開発段階別パイプライン製品
• 腹部大動脈ステントグラフト - セグメント別パイプライン製品
• 腹部大動脈ステントグラフト - 地域別パイプライン製品
• 腹部大動脈ステントグラフト - 規制経路別パイプライン製品
• 腹部大動脈ステントグラフト - 推定承認日別パイプライン製品
• 腹部大動脈ステントグラフト - 進行中の臨床試験

第4章 腹部大動脈ステントグラフト- 各社開発中のパイプライン製品

• 腹部大動脈ステントグラフト企業- 開発段階別のパイプライン製品
• 腹部大動脈ステントグラフト- 開発段階別パイプライン製品

第5章 腹部大動脈ステントグラフト企業と製品概要

• Affluent Medical SASU
• Angiolutions UG
• BiFlow Medical Ltd会
• Cook Medical Inc
• Cytograft Tissue Engineering Inc
• Endologix LLC
• Endoluminal Sciences Pty Ltd
• Hadassah Medical Center
• Johns Hopkins University
• Kawasumi Laboratories Inc
• Lombard Medical Technologies Inc.
• Lombard Medical Technologies Ltd
• Medtronic Plc
• MicroPort Scientific Corp
• St. Jude Medical LLC
• Terumo Aortic
• University of Colorado Denver
• University of Limerick
• Venus Medtech Hangzhou Inc

第6章 腹部大動脈ステントグラフト-最近の動向

第7章 付録

List of Tables

• Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
• Abdominal Aortic Stent Grafts - Pipeline Products by Segment
• Abdominal Aortic Stent Grafts - Pipeline Products by Territory
• Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
• Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
• Abdominal Aortic Stent Grafts - Ongoing Clinical Trials
• Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
• Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
• Abdominal Aortic Stent Grafts - Pipeline Products by Segment
• Abdominal Aortic Stent Grafts - Pipeline Products by Territory
• Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
• Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
• Abdominal Aortic Stent Grafts - Ongoing Clinical Trials

GlobalData's Medical Devices sector report, "Abdominal Aortic Stent Grafts Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Abdominal Aortic Stent Grafts pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Abdominal aortic stent grafts are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Abdominal Aortic Stent Grafts under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Abdominal Aortic Stent Grafts and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Abdominal Aortic Stent Grafts under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Abdominal Aortic Stent Grafts Overview

3 Products under Development

• 3.1 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development
• 3.2 Abdominal Aortic Stent Grafts - Pipeline Products by Segment
• 3.3 Abdominal Aortic Stent Grafts - Pipeline Products by Territory
• 3.4 Abdominal Aortic Stent Grafts - Pipeline Products by Regulatory Path
• 3.5 Abdominal Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
• 3.6 Abdominal Aortic Stent Grafts - Ongoing Clinical Trials

4 Abdominal Aortic Stent Grafts - Pipeline Products under Development by Companies

• 4.1 Abdominal Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
• 4.2 Abdominal Aortic Stent Grafts - Pipeline Products by Stage of Development

5 Abdominal Aortic Stent Grafts Companies and Product Overview

• 5.1 Affluent Medical SASU Company Overview
  • 5.1.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Angiolutions UG Company Overview
  • 5.2.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 BiFlow Medical Ltd Company Overview
  • 5.3.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Cook Medical Inc Company Overview
  • 5.4.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Cytograft Tissue Engineering Inc (Inactive) Company Overview
  • 5.5.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Endologix LLC Company Overview
  • 5.6.1 Endologix LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Endoluminal Sciences Pty Ltd Company Overview
  • 5.7.1 Endoluminal Sciences Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Hadassah Medical Center Company Overview
  • 5.8.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Johns Hopkins University Company Overview
  • 5.9.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Kawasumi Laboratories Inc Company Overview
  • 5.10.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Lombard Medical Technologies Inc. Company Overview
  • 5.11.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Lombard Medical Technologies Ltd (Inactive) Company Overview
  • 5.12.1 Lombard Medical Technologies Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Medtronic Plc Company Overview
  • 5.13.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 MicroPort Scientific Corp Company Overview
  • 5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 St. Jude Medical LLC Company Overview
  • 5.15.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Terumo Aortic Company Overview
  • 5.16.1 Terumo Aortic Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 University of Colorado Denver Company Overview
  • 5.17.1 University of Colorado Denver Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 University of Limerick Company Overview
  • 5.18.1 University of Limerick Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Venus Medtech Hangzhou Inc Company Overview
  • 5.19.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Abdominal Aortic Stent Grafts- Recent Developments

• 6.1 Aug 30, 2024: MicroPort Scientific Reports Earnings Results for the Half Year Ended June 30, 2024
• 6.2 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
• 6.3 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference
• 6.4 Aug 08, 2024: Terumo India Launches Treo Abdominal Stent-graft System
• 6.5 Jun 13, 2024: Medtronic Confirms Global Layoffs
• 6.6 Mar 14, 2024: Endologix to Present at Upcoming LSI US '24 Emerging Medtech Summit
• 6.7 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
• 6.8 Jan 31, 2024: First Patient Treated in the Clinical Study of the ZENITH FENESTRATED+ Endovascular Graft
• 6.9 Sep 21, 2023: Microport Endovastec Completes the First Clinical Implantation of Minos Stent Graft System in Azerbaijan

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer